Crinetics Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $1,031 | $361 | $0 | $0 |
Gross Profit | 72 | 361 | 188 | -770 |
EBITDA | -129,112 | -110,480 | -93,957 | -87,027 |
EBIT | -130,071 | -111,405 | -94,745 | -87,797 |
Net Income | -115,637 | -96,774 | -80,595 | -76,828 |
Net Change In Cash | 1,031 | 361 | 0 | 0 |
Free Cash Flow | -89,053 | -89,691 | -65,703 | -63,351 |
Cash | 53,726 | 94,569 | 264,545 | 317,269 |
Basic Shares | 93,791 | 93,102 | 91,494 | 80,091 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $1,039 | $4,013 | $4,737 | $1,078 |
Gross Profit | 1,039 | 4,013 | 4,737 | 1,078 |
EBITDA | -338,854 | -221,510 | -166,899 | -106,780 |
EBIT | -341,639 | -222,608 | -167,882 | -107,702 |
Net Income | -298,408 | -214,529 | -159,954 | -106,719 |
Net Change In Cash | 1,039 | 4,013 | 4,737 | 1,078 |
Free Cash Flow | -229,814 | -170,995 | -116,861 | -89,024 |
Cash | 264,545 | 54,897 | 32,672 | 200,695 |
Basic Shares | 80,783 | 58,071 | 51,982 | 38,436 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$1.23 |
2025-03-31 | -$1.04 |
2024-12-31 | -$0.88 |
